SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Idea: SARM1 NADase Inhibition for Axonal Preservation

idea 2,420 words KG: SARM1 2026-03-24

kind:idea kind:therapy-idea section:ideas state:published evidence:strong

Contents

SARM1 NADase Inhibition for Axonal Preservation

Knowledge Graph

Related Hypotheses (11)

Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53 Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention fo
Score: 0.47 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 PARP1 Inhibition Therapy
Score: 0.58 Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.51

HDAC3-Selective Inhibition for Clock Reset
Score: 0.46 Axonal RNA Transport Reconstitution
Score: 0.45 Glycine-Rich Domain Competitive Inhibition
Score: 0.43 Low Complexity Domain Cross-Linking Inhibition
Score: 0.42 Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.39 Synaptic Vesicle Tau Capture Inhibition
Score: 0.34

Related Analyses (7)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived

Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived

Related Experiments (6)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40 Sirtuin Pathway Dysfunction Validation in Parkinson's Diseas
clinical · proposed · Score: 0.40 Endothelium-specific TBK1 knockdown in atherosclerosis model
validation · proposed · Score: 0.90 TBK1-PAK1IP1-PAK1 signaling pathway analysis
exploratory · proposed · Score: 0.90

LC-MS/Western blot analysis of TBK1 in atherosclerotic arter
exploratory · proposed · Score: 0.80

See Also (9)

MAPK Signaling Pathways in Neurodegeneration
mechanism · KG edge: activates Alzheimer Indonesia
institution · KG edge: activates BAX Gene
gene · KG edge: activates nad-augmentation-therapy-early-ad
general · KG edge: activates Autophagy Enhancement Drug Screening for Neurodegenerat
experiment · KG edge: activates

Apoptosis in Neurodegeneration
entity · KG edge: activates Neurodegeneration
disease · KG edge: activates Neuroinflammation PET Imaging in CBS/PSP
diagnostic · KG edge: activates blarcamesine-axon
clinical_trial · KG edge: activates

Knowledge Graph (12 edges)

SARM1 activates DLK

SARM1 activates PUMA

SARM1 activates Ms

SARM1 activates Apoptosis

SARM1 activates Mapk

SARM1 activates GBM

SARM1 therapeutic_target GLIOBLASTOMA

SARM1 therapeutic_target CANCER

SARM1 activates Tumor

SARM1 therapeutic_target Glioma

SciDEX — scidex.ai — Dashboard | Atlas